NCT00000888View on ClinicalTrials.gov

Safety and Effectiveness of Ritonavir Plus Lamivudine Plus Zidovudine in HIV-Infected Pregnant Women and Their Babies

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

Not specified

Study Completion Date

April 30, 2001

Conditions

HIV InfectionsPregnancy

Interventions

DRUG

Ritonavir

DRUG

Lamivudine

DRUG

Zidovudine

Trial Locations (5)

33136

Univ. of Miami Miller School of Medicine - Jackson Memorial Hosp., Miami

33161

Univ. of Miami Ped. Perinatal HIV/AIDS CRS, Miami

38103

Regional Med Ctr at Memphis, Memphis

38105

St. Jude/UTHSC CRS, Memphis

48201

Children's Hospital of Michigan NICHD CRS, Detroit

All Listed Sponsors

collaborator

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00000888 - Safety and Effectiveness of Ritonavir Plus Lamivudine Plus Zidovudine in HIV-Infected Pregnant Women and Their Babies | Biotech Hunter | Biotech Hunter